Intermediate for Carfilzomib. Carfilzomib (trade name: Kyprolis) is an anti-cancer drug acting as a selective proteasome inhibitor. Carfilzomib has been approved by the U.S Food and Drug Administration on July 20, 2012.


Product Name:                  (S)-4-(tert-Butoxycarbonylamino)-2,6-dimethyl-1-hepten-3-one

Synonyms:                         N/A

CAS Number:                     247068-81-1

Molecular Weight:            255.3564

Molecular Formula:          C14H25NO3

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               CC(C[C@@H](C(=O)C(=C)C)NC(=O)OC(C)(C)C)C


  • $346.00
  • Ex Tax: $346.00

Available Options